ALLOSTEROS THERAPEUTICS, INC.
Allosteric small molecule inhibitors of CaMKII (Ca2+/calmodulin-dependent protein kinase II) for type 2 diabetes and cardioprotection
- Sector
- Biotech
- Headquarters
- Palo Alto, X1
- Founded
- 2009
- Latest Form D
- $286K, Aug 2012
- Total capital
- $1.8M
- Federal grants
- $492K
- 2 awards · 2016–2017
- Rank in peer group#275 of 502
- Private capital raised
- $1.3M
- 2 Form D · last Aug 2012
- 170 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 4 pending · first 2018
- Rank in peer group#57 of 502
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Advancing Allosteric CaMKII Inhibitors to Treat Multiple Novel Pathways in Diabetes$243K
- Federal grantHealth and Human S · Phase I · Optimizing active site inhibitor of CaMKII: A Novel Target in Atrial Fibrillation$249K
- Private capital raisedForm D · SEC · 2nd filing$286K
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#57 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Howard SchulmanResearcherExecutive Officer, DirectorLinked by $492K in grants as PI
- Mark AndersonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 5- GrantedCaMKII INHIBITORS AND USES THEREOFUSPTOUS 9,951,061
- PendingCamkii Inhibitors And Uses ThereofUSPTOApplication PCTUS2015048640
- PendingCaMKII INHIBITORS AND USES THEREOFUSPTOApplication 62046450
Show all 5 patent records
- CaMKII INHIBITORS AND USES THEREOFApr 24, 2018 · US 9,951,061Granted
- Camkii Inhibitors And Uses ThereofApplication PCTUS2015048640Pending
- CaMKII INHIBITORS AND USES THEREOFApplication 62046450Pending
- CaMKII INHIBITORS AND USES THEREOFApplication PCTUS2014020700Pending
- CaMKII INHIBITORS AND USES THEREOFApplication 61773779Pending
Related companies, and why
- ZYWIE LLCSimilar federal contract value in Biotech · null in contracts
- ORPRO THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- BIOLYTX PHARMACEUTICALS CORPSimilar federal contract value in Biotech · null in contracts
- Atrin PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- PANTHERICS INCORPORATEDSimilar federal contract value in Biotech · null in contracts
- MITOTHERAPEUTIX, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .